Admission Date:  [**2140-6-5**]              Discharge Date:   [**2140-6-25**]  Date of Birth:  [**2058-8-24**]             Sex:   F  Service: MEDICINE  Allergies: Shellfish Derived  Attending:[**First Name3 (LF) 2901**] Chief Complaint: Shortness of breath  Major Surgical or Invasive Procedure: Intubation Cardiac catheterization Central line placement   History of Present Illness: (Patient forgetful per daughter, history obtained from patient, daughter, medical records) This is an 81 year old female with history of Coronary Artery disease status post Myocardial Infarction and stent placement, Congestive Heart Failure, Hypertension, Diabetes Mellitus, recent surgery and chemotherapy, transferred from OSH with pulm edema, ruled in for MI at OSH wit TnI 0.16, CK 178, MB 6.7, index 3.8.
Had received at OSH 80mg lasix, was started on nitro gtt.
Patient was put on NIPPV, received lasix 80mg x1, nitro gtt, was started on hep gtt, no floey 2/2 blood clots from urethra.
On review of symptoms, she denies any prior history of stroke, TIA, deep venous thrombosis, pulmonary embolism, bleeding at the time of surgery, myalgias, joint pains, cough, hemoptysis, black stools or red stools.
All of the other review of systems were negative except for SOB, dysuria since radiation therapy started.
The cardiac index calculated using an assumed oxygen  consumption rate was 4l/min/m2.
Successful PTCA and stenting of the proximal LAD with overlapping 2.5 x 23 mm and 2.5 x 18 mm CYPHER DES which were post dilated to 2.75 with a 2.75 x 20 mm NC [**Male First Name (un) **] balloon at 22 ATM.
Successful PCI of in-stent restenosis of the proximal LAD  [**2140-6-10**] ECHO: The left atrium is normal in size.
There is mild regional left ventricular systolic dysfunction with mid- to distal anterior and anteroseptal hypokinesis.
Moderate pulmonary hypertension   Brief Hospital Course: This is an 81 year old female with hx of CAD s/p MI and stents, CHF, HTN, DM, vaginal CA s/p resection/ChemoTx, rad tx before this admission, who presented from OSH with NSTEMI then had a second NSTEMI while here and went into respiratory distress.
# CAD/Ischemia:  Ms. [**Known lastname 78579**] presented with NSTEMI, plan was to send her for cardiac catheterization but she developed respirtory distress on the hospital floor and was intubated.
She is now s/p two Cypher stents to LAD.
She will be dishcharged on ASA 325 mg, Plavix, statin, beta-blocker and ace-inhibitor.
She had no further symptoms during her stay, and her telemetry was unremarkable.
Shortly after being intubated she became febrile and hypotensive.
She wsa started on Vanco/Zosyn for treatment of possible sepsis/PNA.
She was transitioned to Cipro/Zosyn and was treated for a 10 day course.
She remained on the ventilator for > 1 week and was successfully extubated.
She is to continue on Furosemide 40mg [**Hospital1 **].
She was started on Flagyl and will complete a 14 day course.
Blood pressures are now controlled on a regimen of Lisinopril 20mg daily and Metoprolol 100mg TID.
She is to continue on Lasix, ACE-inhibitor and BB.
# Rhythm: Patient had atrial fibrillation with RVR s/p NSTEMI as above.
Anti-coagulation has been held as A-fib was likely in setting of MI.
Patient is to continue on Beta-blocker.
Her home COPD medications were restarted and she continued to have good oxygen saturation on room air (95%) and no reported difficulties breathing.
At time of discharge, she was on lantus 30 units, and a sliding scale of humalog on discharge.
Her primary outpatient oncology team was contact[**Name (NI) **] and she will have further treatment as directed by them once she returns home to [**State 1727**].
Medications on Admission: CURRENT MEDICATIONS: (from notes, patient does not recall): - lasix 60-0-40 - ASA 325 - plavix 75 - lantus 90 qPM - RISS - advair 250/50 [**Hospital1 **] - combivent QId prn - nitro SL - PPI - lisinopril 5 daily - zocor 40 - MV - lopressor 200 [**Hospital1 **] - docusate - MOM - Vit B12   Discharge Medications: 1.
Aspirin 325 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Clopidogrel 75 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Cyanocobalamin 500 mcg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Therapeutic Multivitamin     Liquid Sig: Five (5) ML PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Fluticasone-Salmeterol 250-50 mcg/Dose Disk with Device Sig: One (1) inhalation Inhalation [**Hospital1 **] (2 times a day).
Lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 40 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Tartrate 50 mg Tablet Sig: Two (2) Tablet PO TID (3 times a day).
Metronidazole 500 mg Tablet Sig: One (1) Tablet PO TID (3 times a day) for 7 days.
Insulin Glargine 100 unit/mL Solution Sig: Thirty (30) units Subcutaneous once a day.
Ipratropium-Albuterol 18-103 mcg/Actuation Aerosol Sig: [**1-27**] Puffs Inhalation Q6H (every 6 hours) as needed.
Insulin Aspart 100 unit/mL Solution Sig: Sliding scale Subcutaneous QAC and QHS: As directed by sliding scale.
Potassium Chloride 10 mEq Capsule, Sustained Release Sig: One (1) Capsule, Sustained Release PO once a day.
Discharge Disposition: Extended Care  Facility: [**Month (only) 53281**] Rehabilitation & Nursing Center - [**Location (un) 28318**]  Discharge Diagnosis: Primary diagnosis: Non-ST-elevation MI Secondary diagnoses: CHF exacerbation, systolic Mitral regurgitation C. difficile colitis   Discharge Condition: Stable   Discharge Instructions: You were admitted with a heart attack and difficulty breathing.
You had stents placed in one of your coronary arteries.
You were intubated for difficulty breathing.
You received medications to remove fluid from your lungs and to improve your blood pressure.
Please take all of your medications as prescribed.
Do not miss doses of your plavix and do not stop this medication unless directed by a cardiologist.
- The dosing of your insulin has been changed.
- The dosing of your metoprolol has been changed.
- You will need to take flagyl for another 7 days as directed (antibiotic for c. difficile).
